Oncology Episode Payment Model in Hawaii

Not Applicable

Active, not recruiting

• Conditions: Breast Cancer; Colon Cancer; Lung Cancer
• Interventions: Other: Cancer Episode Payment Model (CEM)

• Registration Number: NCT03523546
• Lead Sponsor: University of Pennsylvania

Brief Summary

The HMSA Cancer Episode Payment Model (CEM) is a payment model designed to test the effects of better care coordination on health outcomes and costs of care for Hawaii Medical Services Association (HMSA) members with cancer who receive chemotherapy.

Detailed Description

The CEM is designed to improve community health, to improve care coordination, quality, and appropriateness of care, to improve patient experience, and to implement a value-based incentive structure that appropriately rewards oncologists for cost-savings and sustained of improved quality of care.

Study Timeline

• Study First Submitted: 2018-04-19
• Study First Submitted QC: 2018-05-01
• Study First Posted: 2018-05-14
• Study Start: 2018-08-01
• Status Verified: 2024-03
• Last Update Submitted: 2024-03-11
• Last Update Posted: 2024-03-13
• Primary Completion: 2026-01-01
• Study Completion: 2026-01-31

Recruitment & Eligibility

• Status: ACTIVE_NOT_RECRUITING
• Sex: All
• Target Recruitment: 7

Inclusion Criteria

• Any oncologist who practices with Hawaii Oncology and is a participating provider.

Read More

Exclusion Criteria

• Any provider who does not practice with Hawaii Oncology.

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Cancer Episode Payment Model	Cancer Episode Payment Model (CEM)	Oncologists in this arm will be paid for each member's episode of care. The episode of care is 6 months in duration. Oncologists will have the opportunity to receive performance-based payments based upon a set of 6 quality metrics.

Primary Outcome Measures

Name	Time	Method
Composite quality score	1 year	Quality metrics included in the oncology model will be compared across the two arms.
Episode cost	6 months	Total spending of oncology patients in the episode will be compared across the two arms.
Utilization of acute and specialty care	6 months	Total utilization of acute and specialty care of oncology patients in the episode will be compared across the two arms

Secondary Outcome Measures

Name	Time	Method
Quality of care at end of life	6 months	Quality measures evaluating use of acute care and palliative care services at the end of life will be compared across the two arms
Survival	one year	All cause mortality will be compared across the two arms

Trial Locations

Locations (1)

Hawaii Oncology; 🇺🇸 Honolulu, Hawaii, United States